Tenon Medical rises on FDA approval of device to treat joint disorder

Tenon Medical

25/03/2025 09:39

** Shares of medical device maker Tenon Medical TNON.O, RIC rise 91.2% to $1.87 premarket

** US FDA has cleared TNON's device, Catamaran SI Joint Fusion System, to treat sacroiliac (SI) joint disorders, co said on Monday

** The device serves a dual function, acting as a standalone treatment for SI joint disorders and providing support and stabilization during spinal fusion procedures

** SI joint is the connection point between the sacrum, a triangular bone at the base of spine, and the ilium, a part of pelvis

** Stock fell 87.6% in the last 12 month

 (Reporting by Kamal Choudhury in Bengaluru)

 ((Kamal.Choudhury@thomsonreuters.com;))